Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

NCT06016855 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Digestive System Neuroendocrine Tumor G1
Digestive System Neuroendocrine Tumor G2
Metastatic Digestive System Neuroendocrine Neoplasm
Metastatic Malignant Neoplasm in the Liver
Pancreatic Neuroendocrine Tumor G1
Pancreatic Neuroendocrine Tumor G2

Interventions

PROCEDURE: Tumor Debulking
DRUG: Lutetium Lu 177 Dotatate
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Copper Cu 64 Dotatate
PROCEDURE: Positron Emission Tomography

Sponsor

Vanderbilt-Ingram Cancer Center